/term/enterprise-value-to-ebitda/OSTO:DOXA Doxa AB (OSTO:DOXA) EV-to-EBITDA
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Doxa AB (OSTO:DOXA) » Definitions » EV-to-EBITDA

Doxa AB (OSTO:DOXA) EV-to-EBITDA : 95.70 (As of Jun. 20, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Doxa AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Doxa AB's enterprise value is kr890.03 Mil. Doxa AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr9.30 Mil. Therefore, Doxa AB's EV-to-EBITDA for today is 95.70.

The historical rank and industry rank for Doxa AB's EV-to-EBITDA or its related term are showing as below:

OSTO:DOXA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -125.54   Med: -5.63   Max: 191.59
Current: 95.71

During the past 13 years, the highest EV-to-EBITDA of Doxa AB was 191.59. The lowest was -125.54. And the median was -5.63.

OSTO:DOXA's EV-to-EBITDA is ranked worse than
94.56% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 15.245 vs OSTO:DOXA: 95.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-20), Doxa AB's stock price is kr1.502. Doxa AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.000. Therefore, Doxa AB's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Doxa AB EV-to-EBITDA Historical Data

The historical data trend for Doxa AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doxa AB EV-to-EBITDA Chart

Doxa AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.64 -9.66 35.98 -34.65 6.28

Doxa AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.58 23.41 1.95 6.28 188.82

Competitive Comparison of Doxa AB's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Doxa AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doxa AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Doxa AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Doxa AB's EV-to-EBITDA falls into.



Doxa AB EV-to-EBITDA Calculation

Doxa AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=890.034/9.3000000000001
=95.70

Doxa AB's current Enterprise Value is kr890.03 Mil.
Doxa AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doxa AB  (OSTO:DOXA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Doxa AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.502/0.000
=N/A

Doxa AB's share price for today is kr1.502.
Doxa AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Doxa AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Doxa AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Doxa AB (OSTO:DOXA) Business Description

Traded in Other Exchanges
Address
Axel Johanssons Gata 4-6, Uppsala, SWE, 754 50
Doxa AB is involved in developing, manufacturing and marketing bioceramic dental products in Sweden. It offers Ceramir Crown and Bridge, a dental cement used for the permanent fixture of dental crowns and bridges.

Doxa AB (OSTO:DOXA) Headlines

No Headlines